References
- Fry L. Psoriasis. Br J Dermatol 1988;119:445-61
- Lebwohl M. Psoriasis. Lancet 2003;361:1197-204
- McCormick A, Flaming D, Charlton J. Morbidity statistics from general practice: fourth national study - 1991–92. London: HMSO, 1995
- Williams HC. Dermatology. In: Stevens A, Raftery J, eds. Health Care Needs Assessment: the Epidemiologically Based Needs Assessment Reviews: Second Series. Oxford: Radcliffe Medical Press, 1997:261-348
- Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996;135:533-7
- Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol 2007;25:535-46
- Hoede K. The problem of heredity of psoriasis. Hautarzt 1957;8:433-8
- Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, et al. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003;149:530-4
- Whyte J, Baughman R, Hanover N. Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964;89:350-6
- Telfer NR, Chalmers RJ, Whale K, et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992;128:39-42
- Mallon E, Young D, Bunce M, et al. HLA-Cw*0602 and HIV associated psoriasis. Br J Dermatol 1998;139:527-33
- Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005;23:681-94
- Harvima RJ, Viinamaki H, Harvima IT, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol 1996;76:467-71
- Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14:1132-4
- O'Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006;5:426-32
- Elder JT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 2001;137:1447-54
- National Health Service, Hospital Episode Statistics. [http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=203] (last accessed 13th June, 2008)
- Davies L, Levell N, Munro CS, et al. Short course cyclosporin therapy for psoriasis: benefits, risks and costs. Br J Dermatol 1997;137(Suppl 50):53
- Menter A, Feldman SR, Weinstein GD, et al. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol 2007;56:31.e1-31.e15
- Lloyd A, Reeves P, Conway P, et al. Economic evaluation of etanercept in the management of chronic plaque psoriasis. Br J Dermatol 2008 Sep 19. [Epub ahead of print doi: 10.1111/j.1365-2133.2008.08863.x]
- Gill L, Goldacre M, Simmons H, et al. Computerised linking of medical records: methodological guidelines. J Epidemiol Community Health 1993;47:316-19
- Mallbris L, Akre O, Granath F, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30
- Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62
- Poole CD, Conway P, Currie CJ. An evaluation of the association between C-reactive protein, the change in C-reactive protein over 1 year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (in press)